Finnrick - Ensuring a Safer and More Transparent Supply Chain
ZZQ Peptides

ZZQ Peptides

Retatrutide

Finnrick tested 5 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from ZZQ Peptides between 24 Jul 2025 and 9 Oct 2025. Test scores average below 4 or some scores below 3, and at least 2 tests, warrant a tentative Finnrick Rating of E (Bad).

Finnrick Rating™
E
BAD
Tentative Rating
ZZQ Peptides
Retatrutide
Tested 5 Samples
Last test 9 Oct 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

Other Retatrutide tests from top-rated vendors:

All Retatrutide tests from ZZQ Peptides

Samples are tested in commercial labs

Tests Count

5

Scores

AVG5.5MIN0.0MAX7.6

Last

9 Oct 2025

First

24 Jul 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
9 Oct 2025View7.215mg14.000mg-6.7%99.81%(no batch ID)No Label / Silver Crimp / Clear Cap Lab EPublic
7 Oct 2025View6.620mg26.900mg+34.5%99.80%July 15, 2025 White Label / Gold Crimp / Clear Cap Lab GPublic
3 Oct 2025View0.05mg
⚠️ Sample does not contain Retatrutide
(no batch ID)No Label / Silver Crimp / Purple CapLab EPublic
19 Sep 2025View6.215mg27.700mg+84.7%99.95%06.02.2025No Label / Silver Crimp / Blue CapLab EPublic
24 Jul 2025View7.65mg5.055mg+1.1%99.75%(no batch ID)No Label / Silver Crimp / Yellow Cap Lab APublic